Introduction
Living things undergo aging process over time. This is nature. During the process of natural senescence, alterations in the genetic signals dictate the direction, the rate, and the consequences of aging. Aging process also occurs in the mitochondrial genome. The genetic components of human mitochondria lie within the circular structure of the mitochondrial DNA (mtDNA) within the mitochondria itself 1, 2 . However, interactions of nuclear DNA (nDNA) and mtDNA dictate the integrity of the structural and functional proteins of mitochondrial machinery and cells. Lack of histone protection and low efficiency of mtDNA repair render mtDNA more susceptible than nDNA to "genetic error" (mutation). As a consequence, mutated mtDNA or nDNA causes alterations in mitochondrial functions, one of which is derangement of oxidative phosphorylation (OXPHOS) and cellular energy failure. Disorders of OXPHOS 3, 4 and mitochondrial disease (MtD) [5] [6] [7] are 2 common names used interchangeably for "mitochondrial cytopathy" 8 . Therefore, knowing the molecular basis of mitochondria, interaction between nDNA and mitochondria, and recognition of the variety of phenotypes of MtD are important steps to the understanding of mitochondrial medicine. chain. They are: (1) nDNA gene mutations that encode subunits of respiratory chain complexes such as complexes I and II; (2) nDNA mutations that interfere with the genes encoding ancillary proteins needed for correct assembly and function of the respiratory chains such as complexes III, IV, and V; and (3) nDNA mutations that interrupt intergenomic signaling and thus the quality of mtDNA. The "double hits" theory may apply to the latter. Regardless of the mechanism, the final consequence would be derangement of cellular OXPHOS, which manifests clinically as MtD. More than a dozen clinical syndromes of MtD have been recognized 11 3. Leber's hereditary optic neuropathy (LHON) is the most frequent cause of maternally inherited, painless, bilateral blindness that occurs in young adults 11 . Pattern reversal visual evoked potentials (VEP) confirm the severity of the optic neuropathy ( Figure 3 ). Movement disorders, dementia, and cardiomyopathy may occur 26 . Cerebral white matter changes resemble multiple scleroses 27 . It is estimated that 75-95% of LHON are caused by mutations of G11778A (40-60%) and G3460A (20%) that affect complex I, and G15257A (15%) that affect complex III. At least 8 major mutations have been recognized 11 .
4. Mitochondrial myopathy, encephalopathy, lactic acidosis, stroke-like episodes (MELAS) syndrome 28, 29 is the most common syndromic manifestation of MtD that occurs in all age groups. The clinical course of MELAS is slowly progressive with stepwise deterioration. The severity of lactic acidosis correlates with the severity of neurologic deficit 30 . Epilepsy is frequent in patients with MELAS. Epilepsia partialis continua or Koshevnikov syndrome may occur 31 .
Calcification of bilateral basal ganglia 32 , ischemic stroke-like lesions ( Figure 1A and B) involving the posterior temporal and parieto-occipital lobes crossing 2 or more arterial territories, and deep white matter changes in watershed areas and subcortical regions are common in patients with MELAS 33 .
Brain single-photon emission computed tomography (SPECT) shows focal hyperperfusion (hyperemia) 34 or regional hypoperfusion 35 at different stages of the disease. Reversible vasogenic edema, focal brain 
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ischemia or "mitochondrial vasculopathy" 35, 36 , neuronal metabolic derangement, and cellular energy failure have been accrued to the characteristic lesions seen on brain magnetic resonance imaging (MRI). Cortical atrophy with dementia is a late consequence of MELAS. A-to-G transition of tRNA Leu (UUR) gene at np 3243 is the most frequent mutation (> 90% of patients) found in both Caucasians and Orientals with MELAS (MELAS/A3243G) 37 54, 55 . Multiple mtDNA deletion is one of the causes of POLIP 56 .
Nonsyndromic Manifestations of Mitochondrial Disease (NSMMtD)
OXPHOS diseases may present with a number of NSMMtD ranging from an isolated neurologic symptom or sign to various combinations with non-neurologic features. Movement disorders manifested by chorea, tremor, hemiballism, ataxia, or dystonia, migrainelike headache, neuropsychiatric manifestations, and endocrine disorders such as hypopituitarism, deficiency of secretion of antidiuretic hormone, hypogonadism, and DM are common combinations. Some other features of central nervous system manifestations may be secondary to organ failure such as hepatic encephalopathy and nephropathy.
Work-up of Suspected MtD
The work-up of suspected MtD, in the order of increasing strength of evidence and difficulty of the techniques and their invasiveness, are listed below. 1. As MtD is notoriously caused by maternal inheritance of a variety of mtDNA mutations, obtaining a detailed family history and pedigree of the index case is of utmost importance. Specific attention must be paid to the family history of a wide range of symptomatology, such as visual disturbance, hearing deficit, migraine-like headache, early onset of stroke-like episodes, familial occurrence of epilepsy, involuntary movements, symptoms suggestive of myopathy or recurrent myoglobinuria, exercise intolerance, unexplained endocrine disorders and renal dysfunction, familial occurrence of early-onset DM, thyroid disorders, etc. 2. Blood tests must include plasma levels of glucose, lactate and pyruvate ratio, creatinine phosphokinase, liver and renal function tests, etc. Following informed consent, collection of mtDNA from among the family members, especially from siblings and maternal relatives, is a key step to the molecular diagnosis. Searching for common mtDNA mutations, such as mtDNA rearrangement, mtDNA deletion, mitochondrial duplication, or point mutation, can be laborious. Determination of heteroplasmy, mosaicism, and mutant load is critical for explaining the heterogeneity of phenotype-genotype correlation [57] [58] [59] [60] . Moreover, the mtDNA mutation loads are selectively amplified through generations 60 and aging 57 . 34, 35 . Magnetic resonance spectroscopy and positron emission tomography are used for the evaluation of regional brain metabolism, electroencephalography for seizure evaluation, VEP for objective assessment of the optic pathways, and nerve conduction studies for quantification of peripheral nerve involvement. 5. Muscle biopsy with a rapid modified Gomoritrichrome stain looking for the presence of "ragged red fibers" (RRF) is the classical standard procedure 62 . An immunohistochemical stain can be very helpful for assessment of the severity of respiratory enzyme deficiency and molecular diagnosis. A deficiency of coenzyme Q 10 in the muscle, but not in blood, has been reported 63 . Oral supplementation of coenzyme Q 10 ameliorated dramatically clinical symptoms 63 . Moreover, electron microscopic examinations of the skeletal muscles may provide additional evidence of mitochondrial disorders when a light microscopic examination of the muscle tissues fails to show typical characteristics of RRF on modified Gomoritrichrome stain. 6. Molecular diagnosis must include the whole mitochondrial genomic screening of the different tissues.
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The mutant load and mosaicism of mitochondrial mutations will determine the phenotypes of the patients. Mitochondrial genomic DNA from muscle tissue, peripheral white blood cells, and hair follicles are samples most often examined in patients suspected to have MtD and in screening for subclinical cases or unaffected family members. The percentage of mutant load of different tissues can be determined that correlate with the clinical manifestation 41 .
Pathologic Changes of MtD
The histopathologic characteristics of MtD have been well studied in skeletal muscle. Three aspects of assessment include light microscopic findings, electron microscopic findings, and molecular diagnosis.
Light microscopic findings
1. The histopathologic finding of RRF of skeletal muscles on modified Gomori-trichrome histochemical stain 62 is a hallmark of mitochondrial disorders.
The mitochondrial dysfunctions could lie within the respiratory chain or outside it. Examples of some conditions of primary MtD due to defects outside the respiratory chain are carnitine palmitoyl transferase, pyruvate dehydrogenase complex, beta-oxidation, or fumarase deficiencies. Conversely, in some types of defects of the respiratory chain, RRF are not seen 15, 31 . Examples are cytochrome c oxidase (COX) deficiency in Leigh's syndrome, and Kojewnikoff syndrome with MELAS 31 . Supplementation of coenzyme Q 10 may be helpful either in familial mitochondrial encephalomyopathy with coenzyme Q deficiency or in patients with Leigh's disease 63, 64 . Furthermore, RRF and ultrastructural changes of mitochondria are also seen in nonMtDs 6, 65, 66 . The ultrastructural alterations of mitochondria in the skeletal muscles of patients with MtD/OXPHOS disease were elucidated in the papers of Shy and Gonatas and Shy et al., and were described as "giant mitochondria", "pleoconial myopathy", and "megaconial myopathy" in 1964 and 1966, respectively 67 . Paracrystalline inclusions may also be seen in normal human muscle, in patients with neuromuscular disorders other than primary MtD, such as in zidovudin myopathy 65 , muscle ischemia 66 , and in certain conditions caused by mitochondrial toxins such as the uncoupling agent 2,4-dinitrophenol. The nature and origin of these inclusions remain unclear. They are composed of proteins that are enzymatically inert 69 , but may be immunoreactive to mitochondrial creatine kinase. 4. Abnormally branched and distorted cristae, concentrically arranged cristae, flattened cristae peripherally, or straight transverse cristae. 5. Mitochondrial matrix may appear empty or vacuolated or contain osmiophilic or other electron-dense bodies. Rarely, the electron-dense bodies consist of amorphous or granular inclusion, which are rich in iron 10 .
6. "Needle-like" crystal inclusions ( Figure 5 ) in the mitochondria with deformed mitochondrial crista 31 .
In essence, understanding of the current concepts of mitochondrial medicine is a milestone in the diagnosis and management of patients with MtD. Figure 5. (A, B) Electron micrographs of a muscle biopsy of a patient with mitochondrial myopathy, encephalopathy, lactic acidosis, stroke-like episodes and A3243G genotype show atypical paracrystalline inclusion ("needle-like" crystal, arrows in 5A). The less electron-dense granules contain cristae-like structures that represent a deteriorating mitochondrion (arrowheads). M = variable sizes of mitochondria; G = densely packed glycogen particle; C = rectangular shaped crystal (arrowheads in 5B) that contains no electron-dense material. From reference 31 with permission from CMA, Beijing, China; courtesy of Prof. Emil Chi of the University of Washington, Seattle, WA, USA. 
